235 related articles for article (PubMed ID: 29134629)
1. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
[TBL] [Abstract][Full Text] [Related]
2. Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study.
Heath L; Gray SL; Boudreau DM; Thummel K; Edwards KL; Fullerton SM; Crane PK; Larson EB
J Am Geriatr Soc; 2018 Oct; 66(10):1948-1955. PubMed ID: 30221747
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
[TBL] [Abstract][Full Text] [Related]
4. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.
Gray SL; Anderson ML; Dublin S; Hanlon JT; Hubbard R; Walker R; Yu O; Crane PK; Larson EB
JAMA Intern Med; 2015 Mar; 175(3):401-7. PubMed ID: 25621434
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use and the risk of fractures among an older adult cohort.
Harding BN; Weiss NS; Walker RL; Larson EB; Dublin S
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):596-603. PubMed ID: 29493043
[TBL] [Abstract][Full Text] [Related]
6. Cumulative Use of Proton Pump Inhibitors and Risk of Dementia: The Atherosclerosis Risk in Communities Study.
Northuis CA; Bell EJ; Lutsey PL; George KM; Gottesman RF; Mosley TH; Whitsel EA; Lakshminarayan K
Neurology; 2023 Oct; 101(18):e1771-e1778. PubMed ID: 37558503
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
[TBL] [Abstract][Full Text] [Related]
8. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
[TBL] [Abstract][Full Text] [Related]
10. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.
Goldstein FC; Steenland K; Zhao L; Wharton W; Levey AI; Hajjar I
J Am Geriatr Soc; 2017 Sep; 65(9):1969-1974. PubMed ID: 28590010
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
Li M; Luo Z; Yu S; Tang Z
Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
[TBL] [Abstract][Full Text] [Related]
12. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
13. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
Moriarty F; Bennett K; Cahir C; Fahey T
J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
[TBL] [Abstract][Full Text] [Related]
14. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
[TBL] [Abstract][Full Text] [Related]
15. No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis.
Hussain S; Singh A; Zameer S; Jamali MC; Baxi H; Rahman SO; Alam M; Altamish M; Singh AK; Anil D; Hussain MS; Ahmad A; Najmi AK
J Gastroenterol Hepatol; 2020 Jan; 35(1):19-28. PubMed ID: 31334885
[TBL] [Abstract][Full Text] [Related]
16. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
17. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
Song YQ; Li Y; Zhang SL; Gao J; Feng SY
PLoS One; 2019; 14(7):e0219213. PubMed ID: 31265473
[TBL] [Abstract][Full Text] [Related]
19. Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study.
Dublin S; Walker RL; Gray SL; Hubbard RA; Anderson ML; Yu O; Crane PK; Larson EB
J Am Geriatr Soc; 2015 Aug; 63(8):1519-26. PubMed ID: 26289681
[TBL] [Abstract][Full Text] [Related]
20. Regular proton pump inhibitor use and incident dementia: population-based cohort study.
Zhang P; Li Z; Chen P; Zhang A; Zeng Y; Zhang X; Huang Q; Liu D; Qi S; Mao C
BMC Med; 2022 Sep; 20(1):271. PubMed ID: 36045363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]